(CLIFTON, NJ) Cantel Medical Corp. has announced that its MediVators, Inc. subsidiary has been granted permission form the FDA to market Rapicide. Rapicide is a high-level disinfectant and sterilant with label claims for a 5 minute 35 degrees Celsius contact time to achieve the high level disinfection of flexible endoscopes in automated endoscope preprocessors. The company says that Rapicide has a reuse life of 28 days which will double the 14 day restriction currently placed on many other products. For more information visit www.cantelmedical.com.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.
From Shortages to Security: How Reusable Health Care Textiles Can Transform Infection Prevention
March 7th 2025Reusable health care textiles enhance infection prevention, reduce waste, and strengthen supply chains. Hygienically clean textiles offer a sustainable, cost-effective alternative to disposable PPE, ensuring patient safety and environmental responsibility.